论文部分内容阅读
目的:观察舒血宁注射液治疗急性脑梗死的临床疗效。方法:将我院收治神经内科住院的脑梗死病人,在保证脑梗死基本治疗基础上,随机分成舒血宁注射液组(试验组)和安慰剂组(对照组),分别于用药前、用药后15 d采用NIHSS神经功能检查量表评分表评定舒血宁注射液及安慰剂治疗急性脑梗死的有效性。结果:用药前两组NIHSS评分表评分无统计学意义(P>0.05),治疗后两组NIHSS评分表评分具有统计学意义(P<0.05)。结论:舒血宁注射液治疗急性脑梗死临床疗效显著,可于临床中推荐应用。
Objective: To observe the clinical efficacy of Shuxuening injection in the treatment of acute cerebral infarction. Methods: The patients with cerebral infarction admitted to Department of Neurology in our hospital were randomly divided into Shuxuening injection group (experimental group) and placebo group (control group) on the basis of the basic treatment of cerebral infarction. Before treatment, medication The effectiveness of Shuxuening injection and placebo in the treatment of acute cerebral infarction was assessed 15 days after NIHSS neurological examination. Results: The scores of NIHSS before and after treatment were not statistically significant (P> 0.05). After treatment, NIHSS scores of two groups were statistically significant (P <0.05). Conclusion: Shuxuening injection in the treatment of acute cerebral infarction clinical significant effect, which can be recommended for clinical application.